drugset / Trial / NCT06513104

A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause

NCT06513104

Phase 1 Completed 47 enrolled Novo Nordisk A/S
NaSequentialOpen-labelTreatment

Summary

The purpose of the study is to investigate if NNC0519-0130 affects the blood levels of a birth control pill that contains the two hormones ethinylestradiol and levonorgestrel. The study will also look into if NNC0519-0130 affects how fast stomach is emptied. Participants will get the new study medicine NNC0519-0130 and will also get birth control pills and paracetamol. The study will last for about 35 weeks.

Timeline

Start
2024-07-18
Primary completion
2025-09-10
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule Oral
Subject NNC0519-0130 Unknown Subcutaneous
Subject ethinyl estradiol Small molecule Oral
Background Acetaminophen Small molecule Oral